Presentation TVT 2021 The SUMMIT Tendyne Trial: Changing the Paradigm of MR Treatment Presenter: Jason Rogers July 21, 2021
Presentation TVT 2021 The REPAIR-MR Trial – Developing New Evidence for Moderate Risk and Elderly DMR Patients Presenter: Patrick McCarthy July 21, 2021
Presentation TVT 2021 How the TRILUMINATE Pivotal Trial will shape TTVI Presenter: Paul Sorajja July 21, 2021
Presentation TVT 2021 Chordal Replacement and Other Technologies Presenter: Mayra Guerrero July 21, 2021
Presentation TVT 2021 Contemporary Outcomes of TMVR With SAPIEN 3/Ultra for Failed Surgical Annuloplasty Rings in the US Presenter: Mayra Guerrero July 21, 2021
Presentation TVT 2021 Impact of MAC on Patient Selection, Procedural Success and 1-Year Outcomes in a Real-World Patient Population Evaluated for TMVI: Results From the CHOICE-MI MAC Study Presenter: Walid Ben Ali July 21, 2021
Presentation TVT 2021 Transapical Mitral Valve Implantation for Treatment of Symptomatic Mitral Valve Disease: A Real-world Multicenter Experience Presenter: Jörg Hausleiter July 21, 2021
Presentation TVT 2021 Case Resolution: LVOT Obstruction After Mitral ViMAC Presenter: Mayra Guerrero July 20, 2021
Presentation TVT 2021 Case Introduction: LVOT Obstruction After Mitral ViMAC Presenter: Mayra Guerrero July 20, 2021
Presentation TVT 2021 Case Resolution: Late Symptomatic Mitral Stenosis After TEER Presenter: Adam Greenbaum July 20, 2021
Presentation TVT 2021 Case Introduction: Late Symptomatic Mitral Stenosis After TEER Presenter: Adam Greenbaum July 20, 2021
Presentation TVT 2021 Case Resolution: Residual ASD After TEER Presenter: Howard Herrmann July 20, 2021
Presentation TVT 2021 Case Introduction: Residual ASD After TEER Presenter: Howard Herrmann July 20, 2021
Presentation TVT 2021 There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach! Presenter: Milton Packer July 20, 2021